Strides Pharma completed its majority stake sale in Pivot Path to an Ascent Capital-led consortium for ₹100 Cr.

Strides Pharma Science LimitedSTAR · Filed with the exchange

The company received ₹75 Cr, with ₹25 Cr due in a year.

Pivot Path is now an Associate Company.

No comments yet. Be the first.

More from Strides Pharma Science Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.